AdvanCell

Sydney, Australia

AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.

Apr 2025

Grant

Top Investors

Catalio Capital ManagementAbingworthSV Health InvestorsSanofi VenturesBrandon Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are AdvanCell's investors?

AdvanCell's investors include Catalio Capital Management, Abingworth, SV Health Investors, Sanofi Ventures, Brandon Capital.

Where is AdvanCell headquartered?

AdvanCell is headquartered in Sydney, Australia.

What does AdvanCell do?

AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.

What stage is AdvanCell at?

AdvanCell is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 13, 2025.

MLA

"AdvanCell — Funding & Investors." VCBacked, April 13, 2025, https://www.vcbacked.co/company/advancell. Accessed July 1, 2026.

APA

VCBacked. (2025). AdvanCell — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/advancell

Wikipedia (cite web)

{{cite web |title=AdvanCell — Funding & Investors |url=https://www.vcbacked.co/company/advancell |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 13, 2025.